Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Shree Ganesh Remedies Limited (NSE: SGRL), ISIN INE414Y01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SGRL last traded at ₹612.05 (-2.21%), with a 52-week range of ₹477.05 to ₹749.85 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 72.84%, FIIs 0.00%, DIIs 0.99%, mutual funds 0.00%.
EquiSense Score (ECS): 44/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.